Chemo or Not?
Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
Black Patients Less Likely to Receive Targeted Radiation
Study finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
by Carolyn Bernhardt
Targeting Cancer in Kids
New studies probe how to match targeted therapies to children with cancer.
by Stephen Ornes
Be Clear About Treatment Goals
People with late-stage cancer must ask what they want from treatment.
by Tyler Santora
Women, Men and Treatment Side Effects
Study shows women have a higher risk of side effects from immunotherapy, adding to evidence that men and women react differently to treatment.
by Delia O'Hara
From the Editor-in-Chief
Cancer and Aging
Cancer cells exploit an aging "infrastructure" to threaten life in those 60 and older.
by William G. Nelson, MD, PhD
Taking Stock of CAR T-Cell Therapy
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
How Common Are Treatment Breakthroughs?
A new study adds nuance to the ‘golden age’ of cancer drug approvals.
by Jon Kelvey
New Guidelines Recommend Exercise for Most Cancer Patients
People in treatment for early-stage cancer should try to get exercise, according to new recommendations.
by Sandra Gordon
Nanoscopic biological computer kills cancer cells, spares healthy ones.
by Natalie Slivinksi